Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation Anne W. HarmonYashomati M. Patel OriginalPaper Pages: 103 - 110
Regulation of the Estrogen Receptor α Minimal Promoter by Sp1, USF-1 and ERα Linda A. deGraffenriedTorsten A. HoppSuzanne A.W. Fuqua OriginalPaper Pages: 111 - 120
A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk Habibul AhsanYu ChenRegina M. Santella OriginalPaper Pages: 121 - 131
Hormonal Factors and Breast Tumor Proliferation: Do Factors that Affect Cancer Risk also Affect Tumor Growth? Nina OestreicherEmily WhitePeggy L. Porter OriginalPaper Pages: 133 - 142
A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer Gary H. LymanStephanie J. GreenSilvana Martino OriginalPaper Pages: 143 - 150
Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen Michael D. JohnsonHong ZuoTodd C. Skaar Report Pages: 151 - 159
VEGF—DT385 Toxin Conjugate Inhibits Mammary Adenocarcinoma Development in a Transgenic Mouse Model of Spontaneous Tumorigenesis R. WildY. YokoyamaS. Ramakrishnan Report Pages: 161 - 171
